These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9767254)
1. E210K mutation in the gene encoding the beta3 chain of laminin-5 (LAMB3) is predictive of a phenotype of generalized atrophic benign epidermolysis bullosa. Mellerio JE; Eady RA; Atherton DJ; Lake BD; McGrath JA Br J Dermatol; 1998 Aug; 139(2):325-31. PubMed ID: 9767254 [TBL] [Abstract][Full Text] [Related]
2. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327 [TBL] [Abstract][Full Text] [Related]
4. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene. Cserhalmi-Friedman PB; Baden H; Burgeson RE; Christiano AM Exp Dermatol; 1998; 7(2-3):105-11. PubMed ID: 9583749 [TBL] [Abstract][Full Text] [Related]
6. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. Christiano AM; Pulkkinen L; Eady RA; Uitto J J Invest Dermatol; 1996 Apr; 106(4):775-7. PubMed ID: 8618020 [TBL] [Abstract][Full Text] [Related]
7. Compound heterozygosity for nonsense ans missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. McGarth JA; Christiano AM; Pulkkinen L; Eady RA; Uitto J J Invest Dermatol; 1996 May; 106(5):1157-9. PubMed ID: 8618058 [TBL] [Abstract][Full Text] [Related]
8. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. McGrath JA; Pulkkinen L; Christiano AM; Leigh IM; Eady RA; Uitto J J Invest Dermatol; 1995 Apr; 104(4):467-74. PubMed ID: 7706760 [TBL] [Abstract][Full Text] [Related]
9. Gentamicin induces Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320 [TBL] [Abstract][Full Text] [Related]
11. Compound heterozygosity for a point mutation and a deletion located at splice acceptor sites in the LAMB3 gene leads to generalized atrophic benign epidermolysis bullosa. Takizawa Y; Hiraoka Y; Takahashi H; Ishiko A; Yasuraoka I; Hashimoto I; Aiso S; Nishikawa T; Shimizu H J Invest Dermatol; 2000 Aug; 115(2):312-6. PubMed ID: 10951252 [TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the LAMB3 gene shared by two Japanese unrelated families with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing. Takizawa Y; Shimizu H; Pulkkinen L; Hiraoka Y; McGrath JA; Suzumori K; Aiso S; Uitto J; Nishikawa T J Invest Dermatol; 1998 Feb; 110(2):174-8. PubMed ID: 9457915 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. McMillan JR; McGrath JA; Pulkkinen L; Kon A; Burgeson RE; Ortonne JP; Meneguzzi G; Uitto J; Eady RA Br J Dermatol; 1997 Jun; 136(6):817-22. PubMed ID: 9217810 [TBL] [Abstract][Full Text] [Related]
15. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa. Posteraro P; Sorvillo S; Gagnoux-Palacios L; Angelo C; Paradisi M; Meneguzzi G; Castiglia D; Zambruno G Biochem Biophys Res Commun; 1998 Feb; 243(3):758-64. PubMed ID: 9501007 [TBL] [Abstract][Full Text] [Related]
16. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families. Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499 [TBL] [Abstract][Full Text] [Related]
17. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes. Floeth M; Bruckner-Tuderman L Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906 [TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing identifies a novel mutation of LAMB3 in a Chinese neonatal patient presented with junctional epidermolysis bullosa. Wang H; Yang Y; Zhou J; Cao J; He X; Li L; Gao S; Mao B; Tian P; Zhou A Medicine (Baltimore); 2018 Dec; 97(49):e13225. PubMed ID: 30544381 [TBL] [Abstract][Full Text] [Related]
19. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa. Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767 [TBL] [Abstract][Full Text] [Related]
20. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online. Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]